AstraZeneca, a company developing it in collaboration with researchers from Oxford, is considered a leader in the race to develop a covid-19 vaccine
The vaccine against covid-19 from the company AstraZeneca and the University of Oxford correctly follows the programmed genetic instructions for the successful creation of strong immunity, a detailed analysis of independent British scientists has shown.
“The vaccine is doing everything we expected and that is good news in our fight against the disease,” said David Matthews, a virology expert at the University of Bristol, who led the vaccine’s research, H1 reports.
AstraZeneca, a company developing it in collaboration with researchers from Oxford, is considered a leader in the race to develop a covid-19 vaccine.
Clinical trials on a wide range of subjects are being conducted in several countries around the world such as Brazil, the United States and the United Kingdom, and the results are expected before the end of the year.
The vaccine, known as ChAdOx1 or AZD1222, was made using a common cold virus called adenovirus taken from chimpanzees, and then about 20 percent of its “instructions” were deleted. This means that the vaccine is impossible to replicate or cause disease in humans.
The focus of researchers in Bristol is focused on assessing how often and accurately the vaccine works according to programmed genetic instructions.
“This is important research because we have been able to confirm that the genetic guidelines for this vaccine are properly followed when they enter a human cell,” Matthews said.
His team’s research has not been reviewed yet.